Editorial Disclosure: GLP-1 Editorial is an editorial publication operated by Ranika Editorial Group LLC. We do not provide medical care, prescribe medication, manufacture or compound medication, or sell GLP-1 treatment. Our rankings are based on our published v3.0 transparency rubric, publicly available provider information, cited sources, and periodic review updates. If a provider relationship, sponsorship, affiliate relationship, or material connection exists, it is disclosed on the relevant page and at /affiliate-disclosure.html.
Last reviewed: May 31, 2026
Next scheduled review: June 30, 2026
Reviewed by: Dr. Sam Saberian, Lead Medical Researcher
Edited by: Julliana Edwards, Editor
Methodology: GLP-1 Editorial v3.0 rubric
Recovery · Provider Directory · Updated 2026-05-11

Recovery & Healing Peptides

Recovery peptides target soft-tissue healing, gut barrier repair, and inflammation modulation. The most-prescribed compounds via U.S. telehealth in 2026 are BPC-157, TB-500, KPV, and the dual stack BPC-157/TB-500. None are FDA-approved; legitimate suppliers dispense via 503A pharmacies with HPLC certificates of analysis.

7 peptides covered v3.0 rubric Updated 2026-05-11 Availability varies by state + DC
SS
Editorial team
Dr. Sam Saberian · Lead Medical Researcher
Medical review by Alen A. Schwartz, MD · Edited by Julliana Edwards · Last updated 2026-05-11

Peptides in this category

Recovery
BPC-157
Body Protection Compound-157
 Recovery
TB-500
Thymosin Beta-4 fragment
 Recovery
GHK-Cu
Copper peptide, skin & connective tissue
 Recovery
Pentadeca Arginate
PDA, novel synthetic
 Recovery
LL-37
Antimicrobial cathelicidin
 Recovery
KPV
Anti-inflammatory tripeptide
 Recovery
DSIP
Delta Sleep-Inducing Peptide

Top telehealth providers for recovery

See the full provider directory for complete profiles, pricing, and v3.0 transparency scoring.

Editorial team

Reviews authored by Dr. Sam Saberian (Lead Medical Researcher), medically reviewed by Alen A. Schwartz, MD, and edited by Julliana Edwards (Editor). About our team →

Related categories

Important medical and regulatory disclosure: Compounded semaglutide and compounded tirzepatide are not FDA-approved. They are not the same as Ozempic, Wegovy, Mounjaro, or Zepbound. Compounded medications may be prescribed only when clinically appropriate after review by a licensed medical provider. GLP-1 Editorial does not provide medical advice, prescribe medication, manufacture medication, or operate a pharmacy.